MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$1,460K
Free Cash flow
-$14,180K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from maturities of secu...
Stock-based compensation
Amortization of operating lease ...
Others
Negative Cash Flow Breakdown
Purchases of securities
Operating lease liabilities
Prepaid expenses and other asset...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-14,469
-14,697
-13,781
-13,574
Stock-based compensation
1,158
1,362
1,471
1,496
Amortization of operating lease right-of-use assets
1,012
1,142
1,183
1,193
Depreciation
-
-
1,753
-
In-process research and development
-
-
0
-
Depreciation
272
-1,014
-
426
Amortization (accretion) of premiums (discounts) on securities, net
-12
68
134
306
Prepaid expenses and other assets
598
355
-395
11
Accounts payable
-304
200
2
-20
Accrued expenses and other liabilities
248
128
-703
942
Operating lease liabilities
-1,057
-1,146
-1,213
-1,180
Net cash used in operating activities
-13,726
-13,100
-12,375
-11,034
Proceeds from maturities of securities
29,910
25,805
34,750
28,363
Purchases of securities
17,434
11,062
33,719
27,493
Purchases of property and equipment
454
510
244
418
Cash paid in connection with asset acquisition
-
-
0
-
Net cash provided by investing activities
12,022
14,233
787
452
Proceeds from exercise of stock options
102
1,105
32
0
Proceeds from issuance of common stock under employee stock purchase plan
142
-
69
0
Net cash provided by financing activities
244
1,105
101
0
Net increase in cash, cash equivalents and restricted cash
-1,460
2,238
-11,487
-10,582
Cash, cash equivalents and restricted cash at beginning of period
15,628
13,390
24,877
28,648
Cash, cash equivalents and restricted cash at end of period
14,168
15,628
13,390
24,877
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from maturities
of securities
$29,910K
(-34.81%↓ Y/Y)
Proceeds from issuance of
common stock under...
$142K
(63.22%↑ Y/Y)
Proceeds from exercise of
stock options
$102K
(292.31%↑ Y/Y)
Net cash provided by
investing activities
$12,022K
(-64.63%↓ Y/Y)
Net cash provided by
financing activities
$244K
(115.93%↑ Y/Y)
Canceled cashflow
$17,888K
Net increase in
cash, cash...
-$1,460K
(-121.44%↓ Y/Y)
Canceled cashflow
$12,266K
Stock-based compensation
$1,158K
(-70.13%↓ Y/Y)
Amortization of operating
lease right-of-use...
$1,012K
(-56.68%↓ Y/Y)
Depreciation
$272K
(-70.50%↓ Y/Y)
Accrued expenses and
other liabilities
$248K
(-36.41%↓ Y/Y)
Amortization (accretion) of
premiums (discounts) on...
-$12K
(-101.22%↓ Y/Y)
Purchases of securities
$17,434K
(54.58%↑ Y/Y)
Purchases of property and
equipment
$454K
(-26.18%↓ Y/Y)
Net cash used in
operating activities
-$13,726K
(49.70%↑ Y/Y)
Canceled cashflow
$2,702K
Net loss
-$14,469K
(54.28%↑ Y/Y)
Operating lease
liabilities
-$1,057K
(53.94%↑ Y/Y)
Prepaid expenses and
other assets
$598K
(473.75%↑ Y/Y)
Accounts payable
-$304K
(-496.08%↓ Y/Y)
Buy us a coffee
Nautilus Biotechnology, Inc. (NAUT)
Nautilus Biotechnology, Inc. (NAUT)